FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1

Trade Groups Comment on Externally Controlled Trials

Two major drug trade associations comment on an FDA draft guidance on external controls in drug and biologic clinical trials.

latest-news-card-1
Medical Devices

Nano-X Imaging Gets Clearance for New X-ray

FDA clears a Nano-X Imaging 510(k) for its Nanox ARC, a stationary X-ray system intended to produce tomographic images of the human musculoskeletal sy...

latest-news-card-1
Medical Devices

Smart Heart Toilet Seat Cleared by FDA

FDA clears a Casana 510(k) for the Heart Seat, a smart toilet seat for measuring heart rate and oxygen saturation.

Human Drugs

ICH M9 Biopharmaceutics Biowaivers Q&A Guidance

FDA publishes an International Council for Harmonization question-and-answer guidance on the M9 guidance on biopharmaceutics classification system-bas...

latest-news-card-1
Federal Register

Panel to Review AstraZeneca RSV Therapy

Federal Register notice: FDA announces a 6/8 Antimicrobial Drugs Advisory Committee meeting to discuss an AstraZeneca BLA for nirsevimab, a long-actin...

latest-news-card-1
Federal Register

Info Collection on Dietary Supplement GMPs

Federal Register notice: FDA sends to OMB an information collection extension entitled Current Good Manufacturing Practice in Manufacturing, Packaging...

latest-news-card-1
Human Drugs

Industry Offers Input on AI in Drug Manufacturing

Pharmaceutical Research and Manufacturers of America tells FDA artificial intelligence offers many opportunities for manufacturers and supports the ag...

latest-news-card-1
Human Drugs

Accelerated Approval Withdrawals Likely to Increase: Attorneys

Two SheppardMullin attorneys say that drug manufacturers seeking accelerated approval should be aware that 10% of drugs approved through the pathway u...

latest-news-card-1
Human Drugs

CGMP Violations in Voyant Beauty Inspection

FDA warns Elkhart, Indiana-based Voyant Beauty about CGMP and other violations in its work as a drug contract manufacturer.

latest-news-card-1

Decentralized Clinical Trial Recommendations

FDA says a new draft guidance will help sponsors and investigators broaden and diversify clinical trial participation through using decentralized clin...